Table III.
Parameter | AA (n = 21) | AS (n = 16) | SS (n = 17) | P-value* | P-value† |
---|---|---|---|---|---|
Thrombin generation | |||||
Lag time (min) | 5.3 (4.8–6.3) | 5.2 (4.7–5.7) | 5.1 (4.2–5.5) | 0.4433 | 0.1052 |
Time to peak (min) | 9.9 (9.2–10.7) | 10.4 (9.2–11.4) | 8.1 (7.7–9.1) | 0.6693 | 0.0001 |
Thrombin peak (nmol/l) | 163.6 (128.8–206.6) | 168.3 (130.6–233.1) | 203.2 (173.1–232.8) | 0.6826 | 0.0887 |
ETP (nmol/l × min) | 1496.0 (1431.5–1770.8) | 1623.4 (1395.1–1851.5) | 1217.5 (1170.0–1329.5) | 0.4573 | <0.0001 |
Clotting | |||||
Onset (min) | 15.0 (12.0–16.5) | 12.3 (10.4–15.4) | 11.6 (8.9–14.8) | 0.2802 | 0.0418 |
Rate (mOD/min) | 78.6 (52.4–99.3) | 60.8 (40.7–83.7) | 83.8 (55.4–120.9) | 0.2060 | 0.2943 |
Change in turbidity | 0.70 (0.57–0.78) | 0.68 (0.61–0.76) | 0.67 (0.56–0.77) | 0.9638 | 0.7277 |
Data are presented as median (IQR).
AA, HbAA individuals (controls); AS, HbAS individuals (sickle cell trait); SS, HbSS individuals (sickle cell disease); ETP, endogenous thrombin potential; mOD, mean optical density.
Comparison of AA to AS.
Comparison of AA to SS.